107 related articles for article (PubMed ID: 26099852)
1. Investigation of the structure of anti-human seminal plasma protein single-chain antibody and its association with linker peptide length.
Jiang X; Zhai J; Song D; Qu Q; Li M; Xing L; Miao S
Mol Med Rep; 2015 Sep; 12(3):4117-4122. PubMed ID: 26099852
[TBL] [Abstract][Full Text] [Related]
2. Study on the relationship between the structure and functions of anti-human cervical cancer single-chain antibody and the lengths of linkers.
Cheng J; Dul Qx; Zhang ; Ren Yf; Zhang Ba; Feng Xd
Eur J Gynaecol Oncol; 2016; 37(2):171-7. PubMed ID: 27172740
[TBL] [Abstract][Full Text] [Related]
3. Optimization modeling of single-chain antibody against hepatoma based on similarity algorithm.
Zhao ZJ; Chen JT; Yuan JY; Yin XX; Song HY; Wang XC
Int J Clin Exp Med; 2015; 8(9):14827-36. PubMed ID: 26628964
[TBL] [Abstract][Full Text] [Related]
4. Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions.
Yamauchi S; Kobashigawa Y; Fukuda N; Teramoto M; Toyota Y; Liu C; Ikeguchi Y; Sato T; Sato Y; Kimura H; Masuda T; Ohtsuki S; Noi K; Ogura T; Morioka H
Molecules; 2019 Jul; 24(14):. PubMed ID: 31323851
[TBL] [Abstract][Full Text] [Related]
5. Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application.
Khantasup K; Chantima W; Sangma C; Poomputsa K; Dharakul T
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):404-17. PubMed ID: 26683180
[TBL] [Abstract][Full Text] [Related]
6. Construction of an scFv library by enzymatic assembly of V(L) and V(H) genes.
Kato M; Hanyu Y
J Immunol Methods; 2013 Oct; 396(1-2):15-22. PubMed ID: 23916870
[TBL] [Abstract][Full Text] [Related]
7. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of a bacterial single-chain antibody fragment specific to B-cell-activating factor of the TNF family.
Cao P; Tang XM; Guan ZB; Diao ZY; Zhang SQ
Protein Expr Purif; 2005 Oct; 43(2):157-64. PubMed ID: 16023370
[TBL] [Abstract][Full Text] [Related]
9. V
Fernández-Quintero ML; Hoerschinger VJ; Lamp LM; Bujotzek A; Georges G; Liedl KR
Proteins; 2020 Jul; 88(7):830-839. PubMed ID: 31904133
[TBL] [Abstract][Full Text] [Related]
10. Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody.
Shanehbandi D; Majidi J; Kazemi T; Baradaran B; Aghebati-Maleki L
Hum Antibodies; 2017; 26(1):1-6. PubMed ID: 28269762
[TBL] [Abstract][Full Text] [Related]
11. Crystallization of single-chain Fv proteins.
Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
[TBL] [Abstract][Full Text] [Related]
12. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
13. The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine.
Jain S; Aresu L; Comazzi S; Shi J; Worrall E; Clayton J; Humphries W; Hemmington S; Davis P; Murray E; Limeneh AA; Ball K; Ruckova E; Muller P; Vojtesek B; Fahraeus R; Argyle D; Hupp TR
PLoS One; 2016; 11(2):e0148366. PubMed ID: 26894679
[TBL] [Abstract][Full Text] [Related]
14. Insilico analysis of three different tag polypeptides with dual roles in scFv antibodies.
Mohammadi M; Nejatollahi F; Sakhteman A; Zarei N
J Theor Biol; 2016 Aug; 402():100-6. PubMed ID: 27113782
[TBL] [Abstract][Full Text] [Related]
15. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
[TBL] [Abstract][Full Text] [Related]
16. An unusual cysteine V
Attallah C; Aguilar MF; Garay AS; Herrera FE; Etcheverrigaray M; Oggero M; Rodrigues DE
Mol Immunol; 2017 Oct; 90():143-149. PubMed ID: 28755586
[TBL] [Abstract][Full Text] [Related]
17. Effect of linker length between variable domains of single chain variable fragment antibody against daidzin on its reactivity.
Yusakul G; Sakamoto S; Pongkitwitoon B; Tanaka H; Morimoto S
Biosci Biotechnol Biochem; 2016 Jul; 80(7):1306-12. PubMed ID: 27116996
[TBL] [Abstract][Full Text] [Related]
18. The effect of varying the peptide linker length in a single chain variable fragment antibody against wogonin glucuronide.
Paudel MK; Sakamoto S; Van Huy L; Tanaka H; Miyamoto T; Morimoto S
J Biotechnol; 2017 Jun; 251():47-52. PubMed ID: 28392422
[TBL] [Abstract][Full Text] [Related]
19. [Construction and expression of single-chain Fv antibody against human VEGF].
Wang D; Yang X; Yuan Q
Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):526-9. PubMed ID: 11798812
[TBL] [Abstract][Full Text] [Related]
20. [Construction and expression of single chain Fv antibody against human bladder carcinoma].
Zhang M; Yu L; Huang H
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):792-5. PubMed ID: 16201198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
